Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: results of a randomised double-blind study
Article in RMD Open (February 2024)
The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.
Article in RMD Open (February 2024)
Article in Internal Medicine Journal (November 2023)
Article in Annals of the Rheumatic Diseases (September 2023)